Pfizer, MorphoSys and Incyte Enter into Clinical Trial Collaboration for Monjuvi (tafasitamab-cxix) in Combination with TTI-622, a Fusion Protein Directed Against CD47 Read more
Amylyx Pharmaceuticals Announces Health Canada Approval of ALBRIOZA for the Treatment of ALS Read more
Oxford BioTherapeutics Announces Research Collaboration with ImmunoGen to Develop Novel Antibody-Drug Conjugates Read more
FDA Approves Lilly and Incyte’s OLUMIANT (baricitinib) As First and Only Systemic Medicine for Adults with Severe Alopecia Areata Read more
Everest Medicines Announces Approval of Trodelvy in China for Second-Line Metastatic Triple-Negative Breast Cancer Read more
Coave Therapeutics and ABL enter into strategic collaboration to develop gene therapy manufacturing processes and create joint capabilities for process development of AAV-based gene therapy Read more